Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Prosiding University Research Colloquium
Siti Zulfatul Afifah
Universitas Muhammadiyah Surakarta
Humanities Computer Science & IT Environmental Science Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Anticoagulant Complications in Coronavirus Disease (Covid-19) Patients: Literature Review Siti Zulfatul Afifah; S Sulistyani
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Mahasiswa (Student Paper Presentation) A
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (208.768 KB)

Abstract

The most common thrombotic complication in severe COVID-19 patients is venous thromboembolism, following the events of venous and arterial thrombosis are deep vein thrombosis, pulmonary embolism, ischemic stroke, myocardial infarction, and systemic arterial embolism. Patients with COVID-19 often have a thrombosis incidence of 31%. Anticoagulation is a therapy to treat thrombosis as a complication of COVID-19. Administration of anticoagulants causes several complications, including bleeding that can cause death. Objective: to determine the complications of anticoagulation in patients with coronavirus disease (COVID-19). Methods: This research was written as a variety of literature with a narrative database analysis method which includes Google Scholar, Pubmed, Research Gate. Results: At the article collection stage, 1,586 titles were obtained from 3 search engines. After screening, the authors found 20 articles discussing anticoagulant complications in patients with coronavirus disease (covid-19). From the data obtained, it can be concluded that most studies show that the use of anticoagulants in COVID-19 patients has minor, major bleeding to death.
Co-Authors S Sulistyani